{
    "data": [
        {
            "id": "690433b1ecb8a7000145daad",
            "title": "Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>MediciNova Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MNOV\" target=\"_blank\">MNOV</a>) shares surged 87.39% to $2.23 in after-hours trading on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Check out the current price of <a href=\"https://www.benzinga.com/quote/MNOV#Nasdaq\" target=\"_blank\">MNOV stock here</a>. </em></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Publication Announcement</h2><!--/$--><!--$--><p class=\"block core-block\">The California-based biopharmaceutical company said on Thursday that its research was published in the Journal of Atherosclerosis and Thrombosis, the official publication of the Japan Atherosclerosis Society and the Asian Pacific Society of Atherosclerosis and Vascular Disease.</p><!--/$--><!--$--><p class=\"block core-block\">The study, \"Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for Atherosclerosis,\" was carried out in collaboration with a Japanese academic research group.</p><!--/$--><!--$--><div class=\"sc-ewfYpr ctXQJP\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Research Results</h2><!--/$--><!--$--><p class=\"block core-block\">According to the company, the study showed that MN-002, the primary metabolite of the oral bioavailable small molecule MN-001 (tipelukast), increased cholesterol efflux in macrophages by upregulating transport proteins ABCA1 and ABCG1.</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Yuichi Iwaki</strong>, MediciNova president and CEO, said the collaborative research \"provides mechanistic insight into how MN-001 and its metabolite MN-002 may influence cholesterol and lipid metabolism.\"</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Clinical Development</h2><!--/$--><!--$--><p class=\"block core-block\">Prior clinical research demonstrated that MN-001 significantly impacted patients with Type 2 diabetes and improved serum lipid profiles in patients with hypertriglyceridemia and non-alcoholic fatty liver disease (NAFLD).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The clinical-stage company is nearing completion of enrollment for a randomized, placebo-controlled, double-blind Phase 2 study in patients with hypertriglyceridemia, type 2 diabetes, and NAFLD.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Stock Performance</h2><!--/$--><!--$--><p class=\"block core-block\">MediciNova reported <a href=\"https://www.benzinga.com/quote/MNOV/earnings\" target=\"_blank\">second-quarter earnings</a> on Aug. 14, with a loss of 7 cents per share, beating the 10-cent loss analysts expected. Revenue totaled $134,600, exceeding expectations. </p><!--/$--><!--$--><p class=\"block core-block\">The company is scheduled to report third-quarter results Nov. 12.</p><!--/$--><!--$--><p class=\"block core-block\">MediciNova's 52-week range is $1.13 to $2.55, and its market capitalization stands at $57.87 million.</p><!--/$--><!--$--><p class=\"block core-block\">The stock is down 44.13% year to date.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action: </strong>According to <a href=\"https://www.benzinga.com/quote/MNOV#Nasdaq\" target=\"_blank\">Benzinga Pro</a> data, MediciNova closed Thursday's regular session at $1.19, up 0.85%.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Benzinga Edge Stock Rankings indicate</strong> that MNOV has a negative price trend across all time frames. <a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" rel=\"noreferrer noopener\" target=\"_blank\">Track the performance of other players</a> in this segment.</p><!--/$--><!--$--><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48549729\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/markets/equities/25/10/48549160/amazon-netflix-apple-reddit-and-coinbase-why-these-5-stocks-are-on-investors-radars-today\" target=\"_blank\"><strong>Amazon, Netflix, Apple, Reddit And Coinbase: Why These 5 Stocks Are On Investors’ Radars Today</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo Courtesy: meeboonstudio on Shutterstock.com</em></p><!--/$--><!--$--><p class=\"block core-block\"><strong>Disclaimer:</strong> This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/A-Businessman-In-A-Suit-Interacts-With-A.jpeg",
            "link": "https://www.benzinga.com/markets/equities/25/10/48549729/why-did-medicinova-stock-mnov-jump-over-87-in-after-hours-trading",
            "pub_date": "2025-10-31 11:57:40",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690434dfecb8a7000145daba",
            "title": "OpenAI&#39;s Sam Altman Calls Out Tesla After Failing To Get $50K Roadster Refund: &#39;Felt Like A Long Time…&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>OpenAI</strong> founder <strong>Sam Altman </strong>has slammed <strong>Tesla Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TSLA\" target=\"_blank\">TSLA</a>) over the company's highly anticipated Roadster, which could be slated to <a href=\"https://www.benzinga.com/markets/tech/25/10/48453724/tesla-roadster-production-may-be-imminent-as-company-posts-new-job-listing\" target=\"_blank\">start production imminently</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Check out the current price of TSLA </em><a href=\"https://benzinga.com/quote/TSLA\" target=\"_blank\"><em>here</em></a><em>.</em></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">A Tale In Three Acts, Says Sam Altman</h2><!--/$--><!--$--><p class=\"block core-block\">Detailing an email exchange with Elon Musk's EV giant in a post on the social media platform X on Thursday, Altman shared screenshots of emails he sent to Tesla to cancel his Roadster reservation. \"A tale in three acts,\" Altman captioned the post.</p><!--/$--><!--$--><p class=\"block core-block\">The screenshots detail Altman making a reservation for the Roadster back in 2018, paying the $50,000 amount required to reserve the vehicle. However, Altman then shared a screenshot of another email he sent to cancel the booking and initiate a $50K refund, only to find that the purported email doesn't exist anymore.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><em>Tesla didn't immediately respond to </em><a href=\"https://pro.benzinga.com\" target=\"_blank\"><em>Benzinga</em></a><em>'s request for comment.</em></p><!--/$--><!--$--><p class=\"block core-block\">It's worth noting that Tesla's official website is still allowing customers to make reservations for the Roadster, demanding a $5,000 upfront payment and the other $45,000 payment to be made via a wire transfer within 10 days of the initial payment.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><em>Source: Tesla</em></p><!--/$--><!--$--><p class=\"block core-block\">Under the Roadster Reservation Agreement, Tesla says the amount is fully refundable. \"Until you enter into the Motor Vehicle Purchase Agreement, your Reservation may be cancelled at any time through your Tesla Account and for any reason, by either you or us, in which case you will receive a full refund of your Reservation Payment,\" Tesla says.</p><!--/$--><!--$--><p class=\"block core-block\">Adding more context to the matter, Altman, in the replies under the initial post, shared that he \"really was excited for the car!\" adding that delays were understandable, but \"7.5 years has felt like a long time to wait.\"</p><!--/$--><!--$--><!--/$--><!--$--><h2 class=\"wp-block-heading\">Tesla's Roadster Patent, MKBHD Shares Roadster Woes</h2><!--/$--><!--$--><p class=\"block core-block\">The news comes as Tesla had recently <a href=\"https://www.benzinga.com/markets/tech/25/10/48035768/elon-musk-led-tesla-releases-cryptic-teasers-could-this-finally-be-affordable-model-y-or-roadster\" target=\"_blank\">filed a patent application</a> with the <strong>USPTO</strong>, detailing an adaptive aerodynamic system that could suck air through a series of fans to generate downforce. The patent was granted in early August this year.</p><!--/$--><!--$--><p class=\"block core-block\">Meanwhile, Altman isn't the only one looking to cancel his reservation, as popular YouTuber <strong>Marques Brownlee</strong>, aka <strong>MKBHD</strong>, shared that he also recently canceled <a href=\"https://www.benzinga.com/markets/tech/25/09/47955324/tesla-roadster-booking-canceled-by-popular-youtuber-mkbhd-tesla-has-been-sitting-with-my-50-grand-for-eight-years\" target=\"_blank\">one of the two Roadster reservations</a> the influencer made eight years ago, paying the $50,000 reservation fee.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Tesla scores well on Momentum and Quality metrics, while offering satisfactory Growth, but poor Value. Tesla also has a favorable price trend in the Short, Medium and Long term. For more such insights, sign up for<a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" target=\"_blank\"> Benzinga Edge Stock Rankings</a> today!</p><!--/$--><!--$--><p class=\"block core-block\"><em>Check out more of Benzinga’s Future Of Mobility coverage by</em><a href=\"https://www.benzinga.com/topic/mobility\" target=\"_blank\"><em> following this link.</em></a></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48549741\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/markets/tech/25/10/48520789/tesla-cybercab-to-make-apac-debut-at-chinas-annual-import-expo-in-shanghai-optimus-could-also-be-showcased\" target=\"_blank\">Tesla Cybercab To Make APAC Debut At China's Annual Import Expo In Shanghai — Optimus Could Also Be Showcased</a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo courtesy: jamesonwu1972/Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Openai-Ceo-Sam-Altman-Attends-The-Artifi.jpeg",
            "link": "https://www.benzinga.com/markets/tech/25/10/48549741/openais-sam-altman-calls-out-tesla-after-failing-to-get-50k-roadster-refund-felt-like-a-long-time",
            "pub_date": "2025-10-31 12:02:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904633cecb8a7000145e13d",
            "title": "Mohamed El-Erian Warns Some AI Names Will &#39;End Up In Tears&#39; But Supports Limited Winners In AI&#39;s &#39;Rational Bubble&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Mohamed El-Erian</strong>, the chief economic adviser at Allianz, issued a stark warning on Thursday that investments in some AI-related names will “end up in tears,” even as he categorized the boom as a “rational bubble.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>A ‘Rational Bubble’ With Limited Winners</strong></h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">El-Erian argued that while AI is a “major transformational general purpose technology” akin to electricity, the current market frenzy is pulling weaker companies up alongside a “limited number of winners,” he told <a href=\"https://www.youtube.com/watch?v=O5URt06GKUc\" target=\"_blank\">CNBC</a>.</p><!--/$--><!--$--><p class=\"block core-block\">“It’s rational because everybody has an incentive to overinvest in AI because the payoff is so huge,” he stated. “But you’re going to have a relatively limited number of winners. So there’s going to be some losers in there.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Erian Outlines 4 Major AI Risks</strong></h2><!--/$--><!--$--><p class=\"block core-block\">El-Erian distinguished this from an “irrational bubble,” like the dot-com crash, noting that while AI’s impact is real, the “first phase” of major innovation always involves overinvestment.</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">He also highlighted four major risks the U.S. is “not handling well”: the lack of a “diffusion policy” to spread productivity, the threat of “bad actors,” the eventual handling of the bubble, and the focus on “labor displacement versus labor enhancement.”</p><!--/$--><!--$--><p class=\"block core-block\">He warned that if displacement remains the focus, public support for AI could “evaporate.”</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Michael Burry Sends A Cryptic Message On AI</strong></h2><!--/$--><!--$--><p class=\"block core-block\">El-Erian's warning lands in the middle of a fierce debate. ‘Big Short’ investor <strong>Michael Burry</strong> recently issued a <a href=\"https://www.benzinga.com/markets/equities/25/10/48551077/michael-burrys-cryptic-message-on-bubbles-winning-move-is-not-to-play\" target=\"_blank\">cryptic warning</a> that “the only winning move is not to play.”</p><!--/$--><!--$--><p class=\"block core-block\">Other bears, like <strong>GQG Partners</strong>, have called the market “<a href=\"https://www.benzinga.com/markets/equities/25/09/47735517/big-tech-stocks-mirror-dotcom-bubble-but-on-steroids-says-top-analyst-could-repercussions-be-more-pronounced-than-1999-crash\" target=\"_blank\">Dotcom on steroids</a>,” and the<strong> Bank of England</strong> has cited an “<a href=\"https://www.benzinga.com/markets/macro-economic-events/25/10/48117992/boe-warns-of-twin-market-risks-bursting-of-ai-valuation-bubble-loss-of-faith-in-feds-independence-could-trigger-sharp-correction\" target=\"_blank\">AI valuation bubble</a>” as a key global risk.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Conversely, JPMorgan CEO<strong> Jamie Dimon </strong>has <a href=\"https://www.benzinga.com/markets/tech/25/10/48220341/jamie-dimon-says-you-cant-look-at-ai-as-a-bubble-people-should-stop\" target=\"_blank\">dismissed bubble talk</a>, comparing AI to the internet’s dawn, while <strong>Goldman Sachs</strong> argues high valuations are supported by <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48100265/fear-of-an-ai-bubble-this-time-is-different-goldman-says\" target=\"_blank\">strong fundamentals</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>How Can Investors Play The AI Theme?</strong></h2><!--/$--><!--$--><p class=\"block core-block\">Here are a few AI-linked exchange-traded funds that investors can consider.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">The market remains volatile amid the skepticism. The S&amp;P 500, up 16.25% in 2025, hit a new 52-week high of 6,920.34 this week. However, the optimism was checked on Thursday as the tech-heavy Nasdaq 100 fell 1.47% to 25,734.81, before futures pointed to a recovery on Friday.</p><!--/$--><!--$--><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48551382\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/markets/equities/25/09/47735517/big-tech-stocks-mirror-dotcom-bubble-but-on-steroids-says-top-analyst-could-repercussions-be-more-pronounced-than-1999-crash\" target=\"_blank\"><strong>Big Tech Stocks Mirror Dotcom Bubble But On ‘Steroids,’ Says Top Analyst: Could Repercussions Be More Pronounced Than 1999 Crash?</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em><strong>Disclaimer: </strong>This content was partially produced with the help of AI tools and was reviewed and published by Benzinga</em></p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo courtesy: Shutterstock</em><a href=\"https://www.benzinga.com/markets/equities/25/09/47735517/big-tech-stocks-mirror-dotcom-bubble-but-on-steroids-says-top-analyst-could-repercussions-be-more-pronounced-than-1999-crash\" target=\"_blank\"><br/></a></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Is-an-AI-Mirage-Masking-Economic-Trouble.jpeg",
            "link": "https://www.benzinga.com/markets/equities/25/10/48551382/mohamed-el-erian-warns-some-ai-names-will-end-up-in-tears-but-supports-limited-winners-in-ais-rational-bubble",
            "pub_date": "2025-10-31 15:20:32",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69046188ecb8a7000145e123",
            "title": "Nasdaq Settles Lower Amid Decline In Mega-Caps: Investor Fear Increases, Greed Index Remains In &#39;Fear&#39; Zone",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">The CNN Money Fear and Greed index showed an increase in the overall fear level, while the index remained in the “Fear” zone on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\">U.S. stocks settled lower on Thursday, with the Nasdaq Composite dipping more than 350 points during the session, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell the day before.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The central bank, on Wednesday, lowered rates by 25 basis points to 3.75%-4.00% for the second straight meeting. Fed Chair Jerome Powell cautioned that another cut is \"not a foregone conclusion—far from it,\" pushing back against expectations that had built up across financial markets in recent weeks.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Meta Platforms Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/META\" target=\"_blank\">META</a>) shares dipped more than 11% on Thursday after the company unveiled hefty new AI-related capital spending. <strong>Microsoft Corp.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MSFT\" target=\"_blank\">MSFT</a>) fell nearly 3% despite topping analysts’ expectations, while <strong>Alphabet Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GOOG\" target=\"_blank\">GOOG</a>) (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GOOGL\" target=\"_blank\">GOOGL</a>) surged 2.5%.</p><!--/$--><!--$--><p class=\"block core-block\">Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, communication services and information technology stocks recording the biggest losses on Thursday. However, real estate and financial stocks bucked the overall market trend, closing the session higher.</p><!--/$--><!--$--><div class=\"sc-ewfYpr ctXQJP\"></div><!--/$--><!--$--><p class=\"block core-block\">The Dow Jones closed lower by around 110 points to 47,522.12 on Thursday. The S&amp;P 500 dipped 0.99% to 6,822.34, while the Nasdaq Composite fell 1.57% to 23,581.14 during Thursday's session.</p><!--/$--><!--$--><p class=\"block core-block\">Investors are awaiting earnings results from <strong>Exxon Mobil Corp.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/XOM\" target=\"_blank\">XOM</a>), <strong>Chevron Corp.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CVX\" target=\"_blank\">CVX</a>) and <strong>Colgate-Palmolive Co.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CL\" target=\"_blank\">CL</a>) today.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>What is CNN Business Fear &amp; Greed Index?</strong></p><!--/$--><!--$--><p class=\"block core-block\">At a current reading of 37.1, the index remained in the “Fear” zone on Thursday, versus a prior reading of 40.4.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48551356\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong> <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48524289/jim-cramer-likes-toast-but-isnt-buying-shares-yet\" target=\"_blank\">Jim Cramer Likes Toast, But Isn’t Buying Shares—Yet</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Fear-and-Greed.jpeg",
            "link": "https://www.benzinga.com/markets/equities/25/10/48551356/nasdaq-settles-lower-amid-decline-in-mega-caps-investor-fear-increases-greed-index-remains-in-fear-zone",
            "pub_date": "2025-10-31 15:13:15",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690462e7ecb8a7000145e133",
            "title": "Exxon Mobil Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Exxon Mobil Corporation</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/XOM\" target=\"_blank\">XOM</a>) will release earnings results for the third quarter, before the <a href=\"https://www.benzinga.com/quote/XOM/earnings\" target=\"_blank\">opening bell on Friday, Oct. 31.</a></p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect the Spring, Texas-based company to report quarterly earnings at $1.82 per share, down from $1.92 per share in the year-ago period. The consensus estimate for Exxon Mobil's quarterly revenue is $87.71 billion, compared to $90.02 billion a year earlier, according to data from <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The stock benefited recently from a sector-wide rally after U.S. sanctions against Russian oil producers helped push crude prices higher, which directly boosts Exxon’s profitability.</p><!--/$--><!--$--><p class=\"block core-block\">Shares of Exxon Mobil fell 1.5% to close at $114.69 on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\">Benzinga readers can access the latest analyst ratings on the <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie\" target=\"_blank\">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p><!--/$--><!--$--><p class=\"block core-block\">Let's have a look at how Benzinga's most-accurate <a href=\"https://www.benzinga.com/quote/xom/analyst-ratings\" target=\"_blank\">analysts have rated the company</a> in the recent period.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Wells Fargo analyst Sam Margolin initiated coverage on the stock with an Overweight rating and a price target of $156 on Oct. 17, 2025. This analyst has an accuracy rate of 60%.</li>\n<li>Melius Research analyst James West initiated coverage on the stock with a Hold rating and a price target of $111 on Aug. 20, 2025. This analyst has an accuracy rate of 74%.</li>\n<li>Piper Sandler analyst Ryan Todd maintained an Overweight rating and increased the price target from $134 to $145 on Aug. 18, 2025. This analyst has an accuracy rate of 67%.</li>\n<li>Goldman Sachs analyst Neil Mehta reiterated a Neutral rating with a price target of $117 on Aug. 8, 2025. This analyst has an accuracy rate of 66%.</li>\n<li>Morgan Stanley analyst Devin McDermott maintained an Overweight rating and boosted the price target from $134 to $135 on Aug. 4, 2025. This analyst has an accuracy rate of 75%</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Considering buying XOM stock? Here’s what analysts think: </p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>Read This Next:</strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48524289/jim-cramer-likes-toast-but-isnt-buying-shares-yet\" target=\"_blank\"> Jim Cramer Likes Toast, But Isn’t Buying Shares—Yet</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48551372\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Exxon-Mobil.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48551372/exxon-mobil-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts",
            "pub_date": "2025-10-31 15:19:06",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}